IBDEI1E1 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24893,1,5,0)
 ;;=5^Uremia
 ;;^UTILITY(U,$J,358.3,24893,2)
 ;;=Uremia^104733
 ;;^UTILITY(U,$J,358.3,24894,0)
 ;;=599.0^^145^1533^65
 ;;^UTILITY(U,$J,358.3,24894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24894,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,24894,1,5,0)
 ;;=5^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,24894,2)
 ;;=Urinary Tract Infection^124436
 ;;^UTILITY(U,$J,358.3,24895,0)
 ;;=275.42^^145^1533^28
 ;;^UTILITY(U,$J,358.3,24895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24895,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,24895,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,24895,2)
 ;;=Hypercalcemia^59932
 ;;^UTILITY(U,$J,358.3,24896,0)
 ;;=275.41^^145^1533^31
 ;;^UTILITY(U,$J,358.3,24896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24896,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,24896,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,24896,2)
 ;;=Hypocalcemia^60542
 ;;^UTILITY(U,$J,358.3,24897,0)
 ;;=276.7^^145^1533^29
 ;;^UTILITY(U,$J,358.3,24897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24897,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,24897,1,5,0)
 ;;=5^Hyperkalemia/Hyperpotassemia
 ;;^UTILITY(U,$J,358.3,24897,2)
 ;;=Hyperkalemia/Hyperpotassemia^60042
 ;;^UTILITY(U,$J,358.3,24898,0)
 ;;=276.8^^145^1533^32
 ;;^UTILITY(U,$J,358.3,24898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24898,1,4,0)
 ;;=4^276.8
 ;;^UTILITY(U,$J,358.3,24898,1,5,0)
 ;;=5^Hypokalemia/Hypopotassemia
 ;;^UTILITY(U,$J,358.3,24898,2)
 ;;=Hypokalemia/Hypopotassemia^60611
 ;;^UTILITY(U,$J,358.3,24899,0)
 ;;=275.2^^145^1533^26
 ;;^UTILITY(U,$J,358.3,24899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24899,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,24899,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,24899,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,24900,0)
 ;;=276.0^^145^1533^30
 ;;^UTILITY(U,$J,358.3,24900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24900,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,24900,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,24900,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,24901,0)
 ;;=276.1^^145^1533^33
 ;;^UTILITY(U,$J,358.3,24901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24901,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,24901,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,24901,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,24902,0)
 ;;=275.3^^145^1533^27
 ;;^UTILITY(U,$J,358.3,24902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24902,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,24902,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,24902,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,24903,0)
 ;;=250.40^^145^1533^16
 ;;^UTILITY(U,$J,358.3,24903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24903,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,24903,1,5,0)
 ;;=5^DM type II with Nephropathy
 ;;^UTILITY(U,$J,358.3,24903,2)
 ;;=DM type II with Nephropathy^267837^583.81
 ;;^UTILITY(U,$J,358.3,24904,0)
 ;;=790.93^^145^1533^1
 ;;^UTILITY(U,$J,358.3,24904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24904,1,4,0)
 ;;=4^790.93
 ;;^UTILITY(U,$J,358.3,24904,1,5,0)
 ;;=5^Abnormal PSA
 ;;^UTILITY(U,$J,358.3,24904,2)
 ;;=Abnormal PSA^295772
 ;;^UTILITY(U,$J,358.3,24905,0)
 ;;=627.3^^145^1533^3
 ;;^UTILITY(U,$J,358.3,24905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24905,1,4,0)
 ;;=4^627.3
 ;;^UTILITY(U,$J,358.3,24905,1,5,0)
 ;;=5^Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,24905,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,24906,0)
 ;;=607.1^^145^1533^6
 ;;^UTILITY(U,$J,358.3,24906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24906,1,4,0)
 ;;=4^607.1
 ;;^UTILITY(U,$J,358.3,24906,1,5,0)
 ;;=5^Balanitis
